hepatocellular carcinoma
Conditions
Interventions
treatment:re-resection under multi-disciplinary treatment mode in patients with recurrent hepatocellular carcinoma
Sponsors
Peking University International Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients who have undergone radical hepatocellular carcinoma resection; (2) Have not received other anti-tumor therapy before surgery; (3) No residual disease was confirmed by postoperative imaging; (4) ECOG rating =2 or KPS score =50, and the expected survival time is = 3 months; (5) Child-Pugh score A-B;
Exclusion criteria
Exclusion criteria: (1) Recurrence within 3 months after surgery; (2) Patients with extrahepatic metastasis or vascular invasion of tumors; (3) Combined with other tumors; (4) decompensated cirrhosis; (5) The preoperative baseline clinical characteristics and pathological characteristics of intraoperative specimens were incomplete; (6) Patients with missing follow-up data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| disease free survival (DFS); | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival (OS);liver function indicators;Lymphatic metastasis;microvascular invasion;tumor numbers;recurrence time;maximum diameter of tumor; | — |
Countries
China
Contacts
Public ContactShi Wenzai
Peking University International Hospital
Outcome results
None listed